End-to-End Program
Not Your Average CRO/CDMO
Our Commitment to You
Your new drug could be the one that changes someone’s life. As investors in life sciences, we know that each project matters. Whether you place one study or multiple programs with us, we treat each project with the equal care and dedication it deserves, no matter the size or spend.
We are committed to making your project a success. After all, your success is our success. And our success, together, means getting better drugs to people who need them, faster.
Speak with an Altasciences expert today.
TAKE FIVE:
- Watch this video to experience the difference
- Check out our new interactive brochure
- Discover our Proactive Drug Development approach
- Read this blog article: Five Ways Altasciences Simplifies the Drug Development Process for You
- Catch up on our top scientific resources of 2021
Altasciences transforms the traditional outsourcing paradigm by simplifying and streamlining drug development solutions, whether for a single study or multiple programs, to offer an integrated/synchronized approach to CRO and CDMO services from lead candidate selection to clinical proof of concept, and beyond.
Bioanalytical Scientific Guidance from Discovery to Preclinical to Phase IV
From discovery to preclinical to Phase IV, Altasciences’ bioanalytical team of over 260 scientific experts specialized in bioanalysis, ligand binding assays (LBA), mass spectrometry, immunology, biomarkers, flow cytometry, and PCR, operates in three strategic locations in proximity to our preclinical and clinical sites. We aim to provide top quality data for TK, PK, and PD determinations to support your preclinical and clinical studies.
At Altasciences, One Laboratory Sciences moves in unison for the success and acceleration of drug development.
Let’s schedule time to discuss your bioanalytical needs.
You may also be interested in the following:
- Podcast — Three Laboratories - One Vision, with Dr. Lynne Le Sauteur
- Webinar — Managing Challenging Bioanalysis for PK/PD Assessments for Phase I Biologics
- Video — Take a Look Inside our PCR Lab
- Press Release — Altasciences Expands Ligand Binding Laboratory to Meet High Demand for Bioanalytical Solutions
Altasciences transforms the traditional outsourcing paradigm by simplifying and streamlining drug development solutions, whether for a single study or multiple programs, to offer an integrated/synchronized approach to CRO and CDMO services from lead candidate selection to clinical proof of concept, and beyond.
Top Scientific Resources of 2021
![]() |
||||||
With the year coming to an end, we rounded-up some of our most insightful scientific resources from 2021. Check out what you may have missed, discover more about our areas of expertise, and learn how we can help you accelerate your drug development program. |
||||||
![]() |
||||||
|
||||||
![]() |
||||||
|
||||||
![]() |
||||||
|
||||||
![]() |
||||||
|
||||||
![]() |
||||||
|
||||||
Have five more minutes? You may be interested in:
|
Start Your Clinical Trials Sooner
Our clinical trial experts set your drug development program up for success by proactively preparing and performing each critical moving part while others are underway. As a single source for early phase drug development solutions, we integrate and synchronize key CRO/CDMO activities, such as clinic-ready manufacturing, bioanalysis, clinical study conduct, and regulatory review, so that you’re always ready for the next step.
Check out how we do this and experience the difference.
![Clinical Trial: Faster, easier, proactive](/sites/default/files/inline-images/e-bulletin_Clinical-Trial-inforgraph.jpg)
You may also be interested in the following:
Webpages:
Fact Sheet:
Altasciences transforms the traditional outsourcing paradigm by simplifying and streamlining solutions, whether for a single study or multiple programs, to offer an integrated/synchronized approach to CRO and CDMO services from lead candidate selection to clinical proof of concept, and beyond.
Let’s Talk Integrated Clinical and CDMO Solutions
Quality and Excellence with Integrated Clinical and CDMO Solutions
Shawn Connaghan, Executive Vice President of Administration and Quality Management, Manufacturing, discusses how Altasciences’ integrated manufacturing and clinical solutions can benefit your drug development program.
Topics covered:
- Advantages of integrated manufacturing and clinical solutions
- Quick project start-up
- Maintaining high-quality standards
- Adapting to sponsors’ unique needs
![Quick Chat with Shawn Connaghan, Executive Vice President of Administration and Quality Management](/sites/default/files/inline-images/quick%20chat%20Shawn.jpg)
You may also be interested in the following:
- Webpage: Pharmaceutical Contract Manufacturing and Analytical Services
- Webinar: High Potency Manufacturing Solutions
- Webpage: Clinical Trial Services
Altasciences transforms the traditional outsourcing paradigm by simplifying and streamlining solutions, whether for a single study or multiple programs, to offer an integrated/synchronized approach to CRO and CDMO services from lead candidate selection to clinical proof of concept, and beyond.
Expert Support for Your IND/CTA Requirements
Partnering with Altasciences for your IND/CTA needs will ensure that your application to regulatory agencies moves forward as smoothly and efficiently as possible. To reach your milestones on time, we recommend setting up a meeting to consult with us at least six months before your required submission date.
For a more detailed discussion of the regulatory planning process, consult our Preclinical Assessment Planning Guide.
|
We Deliver Your Projects On-Time.
On-Time Delivery
Over the last 12 months, our project management team has played a key role in achieving a 99% on-time delivery success rate on your primary KPIs.
Altasciences’ high-quality project management is key to the success of your drug development programs, and is an integral part of our service offering. Our project management team has extensive expertise in managing studies for a wide range of therapeutic areas in small and large molecules, and will oversee every aspect of your study.
Partner with us to ensure seamless and timely communication for the successful completion of your project.
You may also be interested in the following:
Webpages:
Altasciences transforms the traditional outsourcing paradigm by simplifying and streamlining solutions, whether for a single study or multiple programs, to offer an integrated/synchronized approach to CRO and CDMO services from lead candidate selection to clinical proof of concept, and beyond.
Flow Cytometry Solutions to Support Your Preclinical and Clinical Studies
Altasciences’ offers scalable flow cytometry solutions, and leverages extensive knowledge to help ensure a smooth transition from preclinical to clinical studies. We provide you with:
- Dedicated flow cytometry scientists available to you early in the process to help determine the most appropriate strategy for non-GLP, GLP, and GCP testing
- Extensive knowledge with exploratory and GLP studies from panel development to validation
- Design and development of receptor occupancy (RO) assays
- Strategically located laboratories in both the U.S. and Canada.
- State-of-the-art instrumentation
- Rapid turnaround between sample collection and analysis
Altasciences has the same instrumentation in its U.S. preclinical site and Canadian site, which allows assay transfer for easy transition from preclinical to clinical studies.
Download flow cytometry fact sheet
Speak to a flow scientist for guidance on your assay development or validation strategy.
You may also be interested in the following:
- Webpage: Therapeutic Areas of Clinical Research
- Fact Sheet: First-in-Human Trials Capabilities
- The Altascientist: Facing Bioanalytical Challenges
Altasciences transforms the traditional outsourcing paradigm by simplifying and streamlining solutions, whether for a single study or multiple programs, to offer an integrated/synchronized approach to CRO and CDMO services from lead candidate selection to clinical proof of concept, and beyond.
Overcoming Challenges and Building a Successful Company
Dr. Gautam Ghatnekar, CEO of FirstString Research, shares his secrets to raising capital, recruiting and retaining talent, and overcoming the challenges of getting medicines to the market.
![Overcoming Drug Development Pathway Challenges with FirstString Research CEO Dr. Gautam Ghatnekar](/sites/default/files/inline-images/Podcast_thumbnail_Gautam-Ghatnekar.jpg)
You may also be interested in the following:
- Article: Making Early Phase Drug Development Faster, Better, and More Efficient
- Podcast: Consultant Series ― Chat with Dr. John Atkinson, Founder of Atkinson Toxicology Consulting
- Scientific Publication: Assessment of Subcutaneous Radio-Telemetry Device Implantation in Cynomolgus Monkeys
- Webpage: Comprehensive Clinical Trial Services
Altasciences transforms the traditional outsourcing paradigm by simplifying and streamlining solutions, whether for a single study or multiple programs, to offer an integrated/synchronized approach to CRO and CDMO services from lead candidate selection to clinical proof of concept, and beyond.
Expertise to Support the Approval of your 505(b)(2) or Hybrid Drug Submissions
A generic molecule with a different route of administration, format, strength, or indication from the original reference product requires re-approval for market authorization, partly based on data from the original medicine, and partly on data from new clinical trials on the modified version.
Consult The Altascientist for a review of the requirements for such approval, including a case study outlining three key studies we conducted for a 505(b)(2):
![three key studies we conducted for a 505(b)(2)](/sites/default/files/inline-images/f1558cb3-375a-41f9-8795-bf1dbc710e2b.jpg)
Altasciences ensures a seamless process for your 505(b)(2) or Hybrid medicine submissions, with integrated manufacturing, bioanalysis and comprehensive research support services that can expedite your clinical trials.
Speak with our experts.
Altasciences transforms the traditional outsourcing paradigm by simplifying and streamlining solutions, whether for a single study or multiple programs, to offer an integrated/synchronized approach to CRO and CDMO services from lead candidate selection to clinical proof of concept, and beyond.
You may also be interested in the following:
- Video (3 minutes): Fully Integrated Drug Development Solutions
- Fact Sheet: Multiple Award-Winning CRO
- On-Demand Webinar: Patient Centricity and the Evolving Role of Microsampling